Aaron Fischman, MD

Aaron M. Fischman, MD, FSIR, FCIRSE, FSVM, is Professor of Diagnostic, Molecular and Interventional Radiology, Urology, and Surgery at the Icahn School of Medicine at Mount Sinai in New York City, where he has practiced since 2010. He serves as Program Director of Mount Sinai's nationally recognized IR residency training program — one of the largest and most respected in the United States — and holds board certification in both Diagnostic Radiology and Vascular & Interventional Radiology from the American Board of Radiology. He received his undergraduate degree in Economics from Dartmouth College, completed medical school at SUNY Upstate Medical University in 2004, and trained in Diagnostic Radiology residency at Mount Sinai, where he served as Chief Resident, before completing a fellowship in Vascular and Interventional Radiology.

Dr. Fischman's clinical practice is centered on minimally invasive, catheter-based treatments for conditions that have traditionally required major surgery — with particular expertise in men's health, joint pain, venous disease, and interventional oncology. He is internationally recognized as one of the foremost experts in Prostate Artery Embolization (PAE) for benign prostatic hyperplasia (BPH), having performed thousands of procedures over his career. Dr. Fischman pioneered the transradial (wrist-access) technique for PAE in the United States — allowing the entire procedure to be performed through a small puncture at the wrist, enabling immediate ambulation, same-day discharge, and the elimination of groin access entirely. He was also among the first to develop the use of liquid embolics (n-BCA glue) as the primary embolic agent for PAE, a technically advanced approach that dramatically reduces procedure time, lowers radiation exposure for both patient and physician, and is available at very few centers in the country. The same transradial technique has been applied across Dr. Fischman's practice, including for uterine fibroid embolization, oncologic liver interventions, and prostate embolization. He trains physicians from around the world in these advanced methods, having taught hundreds of interventional radiologists and urologists across North America, Europe, Asia, and Latin America.

As Principal Investigator of the BEST Trial — one of the landmark multicenter clinical trials directly comparing PAE to TURP (transurethral resection of the prostate), the longstanding surgical standard of care for BPH — Dr. Fischman has contributed foundational evidence to establishing PAE's clinical legitimacy and its inclusion in the 2023 American Urological Association (AUA) guidelines. He has also served as Principal Investigator of the BEAT Obesity Trial, investigating a novel minimally invasive bariatric embolization procedure as an alternative to surgery for weight loss. Over the course of his career, Dr. Fischman has been involved in numerous multicenter clinical trials that have helped to define and advance the field of interventional radiology.

Dr. Fischman maintains a broad and active interest in the full spectrum of interventional radiology. His venous disease practice encompasses advanced management of [deep vein thrombosis (DVT), complex and long-dwelling IVC filter removal, superficial varicose vein treatment, and portal venous hypertension, including therapies such as Transjugular Intrahepatic Portosystemic Shunt (TIPS) and Balloon Occlusion Retrograde Transvenous Obliteration of Gastric Varices (BRTO). His interventional oncology practice encompasses minimally invasive treatments for primary and metastatic liver and kidney cancer, including Yttrium-90 radioembolization, transarterial chemoembolization (TACE), and state-of-the-art thermal ablative technologies including microwave ablation and cryoablation. He also performs Genicular Artery Embolization (GAE) for chronic knee, shoulder, and hip pain caused by osteoarthritis — a minimally invasive alternative to steroid injections and joint replacement surgery that targets the abnormal neovascular tissue driving joint pain.

Dr. Fischman has authored over 130 peer-reviewed publications, textbook chapters, and scientific abstracts, and is regularly invited to present at leading national and international meetings in the field. He is an active Fellow of the Society of Interventional Radiology (FSIR), a Corresponding Fellow of the Cardiovascular and Interventional Radiological Society of Europe (FCIRSE), and a Fellow of the Society of Vascular Medicine (FSVM). He is a member of the Alpha Omega Alpha Medical Honor Society, the Radiologic Society of North America, the American Roentgen Ray Society, the Society of Cardiovascular Computed Tomography, and the American College of Phlebology. He has received multiple awards for clinical excellence and teaching, including the Harold A. Mitty Distinguished Educator Award — Teacher of the Year, awarded twice — and has been recognized as a Castle Connolly Top Doctor for eight consecutive years.

In addition to his clinical and research activities, Dr. Fischman is the founder and director of TREAT iR Live an international symposium dedicated to advancing education in interventional radiology technique, with a particular focus on transradial access and advanced embolization methods. The symposium draws attendees from across the globe and has become one of the leading educational platforms in the field.

Dr. Fischman sees patients from across the United States and internationally. Telemedicine consultations are available for out-of-state and international patients. For appointments or referrals, contact his office at 212-241-4046.